These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7661903)

  • 1. Indications for the sclerosing agent polidocanol.
    Duffy DM
    J Dermatol Surg Oncol; 1994 Jul; 20(7):494-5. PubMed ID: 7661903
    [No Abstract]   [Full Text] [Related]  

  • 2. Polidocanol-- a versatile and safe agent?
    Knobloch K
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):250. PubMed ID: 19670128
    [No Abstract]   [Full Text] [Related]  

  • 3. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM
    J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for the sclerosing agent polidocanol: response.
    Geux JJ
    Dermatol Surg; 1995 Jan; 21(1):106-7. PubMed ID: 7600013
    [No Abstract]   [Full Text] [Related]  

  • 5. Endoscopic sclerotherapy for esophageal varices: a prospective, randomised trial of absolute alcohol versus polidocanol.
    Atamkuri SP; Bhargava DK; Sharma MP
    Indian J Gastroenterol; 1988 Apr; 7(2):87-9. PubMed ID: 3360476
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis to polidocanol (Thesit).
    Huber-Riffeser G
    Contact Dermatitis; 1978 Aug; 4(4):245. PubMed ID: 710111
    [No Abstract]   [Full Text] [Related]  

  • 7. Urticaria induced by Etoxisclerol (polidocanol).
    Henriquez-Santana A; Fernandez-Guarino M; González de Olano D; Gonzalez-Cervera J; Huertas-Barbudo B; Aldanondo I
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):261-2. PubMed ID: 18211438
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart failure as a side effect of polidocanol given for oesophageal variceal sclerosis.
    Imperiali G; Terruzzi V; Spotti D; Minoli G
    Endoscopy; 1986 Sep; 18(5):207. PubMed ID: 3780593
    [No Abstract]   [Full Text] [Related]  

  • 9. Polidocanol sclerotherapy for hydroceles and epididymal cysts.
    Sigurdsson T; Johansson JE; Jahnson S; Helgesen F; Andersson SO
    J Urol; 1994 Apr; 151(4):898-901. PubMed ID: 8126821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic reactions to polidocanol for vein sclerosis. Two case reports.
    Feied CF; Jackson JJ; Bren TS; Bond OB; Fernando CE; Young VC; Hashemiyoon RB
    J Dermatol Surg Oncol; 1994 Jul; 20(7):466-8. PubMed ID: 8034842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
    Sallami S; Binous MY; Ben Rhouma S; Chelif M; Hmidi M; Nouira Y; Ben Rais N; Horchani A
    Tunis Med; 2011 May; 89(5):440-4. PubMed ID: 21557180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to 'Treatment of Essential Telangiectasia': Use of Polidocanol.
    Reynolds O
    J Am Acad Dermatol; 1990 Jan; 22(1):148. PubMed ID: 2298961
    [No Abstract]   [Full Text] [Related]  

  • 14. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicystic recurrence of hydrocele testis after sclerosing with polidocanol followed by spontaneous cure.
    Fariña LA; Villavicencio H
    Int Urol Nephrol; 1995; 27(4):449-50. PubMed ID: 8586519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repeated injection sclerotherapy on acid gastroesophageal reflux.
    Sauerbruch T; Wirsching R; Holl J; Gröbl J; Weinzierl M
    Gastrointest Endosc; 1986 Apr; 32(2):81-3. PubMed ID: 3710104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of subcutaneous dialysate leak with polidocanol: case report.
    Sai K; Ishibashi Y; Oota N; Muto S; Kitamura T; Takara Y; Kido M; Nangaku M; Nakao A; Fujita T
    Perit Dial Int; 2004; 24(1):91-3. PubMed ID: 15104351
    [No Abstract]   [Full Text] [Related]  

  • 19. The watermelon stomach: successful treatment by monopolar electrocoagulation and endoscopic injection of polidocanol.
    Cugia L; Carta M; Dore MP; Realdi G; Massarelli G
    J Clin Gastroenterol; 2000 Jul; 31(1):93-4. PubMed ID: 10914790
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol.
    Hussar DA; Stevenson T
    J Am Pharm Assoc (2003); 2010; 50(5):658-62. PubMed ID: 20833626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.